Two Biotechs I’m Buying Amid an Overbought Market
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
As retailers get hit and AI-plays bubble over, I’ve got my sights on these two promising biopharma stocks.
Retail investors should keep an eye on this line to determine what the pros are doing after the landmark settlement.
As we get big news from the Meta case and await Nvidia earnings, here’s a company I’m adding to my shopping list.
I’m opening small positions in these names that are turning the software sector on its head.
There are still multiple level of resistance ahead. Here’s how we’re playing the stock.
On a slow news day we’re looking to build onto these three small-cap positions.
Is inflation high because of tariffs and the Iran war, or just because the economy is running too hot?
Bonds are up, and people are talking, so let’s join in and discuss their price action.
Here’s what it means when a rate-friendly session fails to attract buying. Plus, Dick’s results raise a familiar question..
This Pro Portfolio stock has fallen sharply this month but right to a good support level.